# HEPARIN SODIUM
> **ANDA211007** · Abbreviated New Drug Application (Generic) · Sponsor: EMERGE BIOSCIENCE · Approved 2019-05-28
## Drug
- **FDA Application Number:** ANDA211007
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HEPARIN SODIUM
- **Generic name:** HEPARIN SODIUM
- **Active ingredients:** HEPARIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** EMERGE BIOSCIENCE
- **Manufacturer:** Meitheal Pharmaceuticals Inc.
- **First approval:** 2019-05-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211007)
---
*AI Analytics · CC0 1.0*